Critical Illness Polyneuropathy Developing In The Early Period After An Epileptic Seizure: Two Case Reports
Journal of Emergency Medicine Case Reports · 31.03.2026 · 17 (1) · 14-16
DOI: 10.33706/jemcr.1738131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Emergency Medicine Case Reports, online erschienen am 31.03.2026. Verfasst von Şeyma Ataman und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Critical illness polyneuropathy (CIP) is characterized by muscle weakness and atrophy in intensive care patients. Although recovery may occur by addressing the underlying cause, plasmapheresis or immunoglobulin therapy may be necessary in severe cases. We present two female patients (aged 76 and 52) who developed CIP in the early phase following epileptic seizures. CIP was suspected due to difficulty in ventilator weaning, and EMG confirmed the diagnosis. Both patients underwent five sessions of plasmapheresis and were successfully weaned from the ventilator, regaining full (5/5) muscle strength in all extremities. Early diagnosis is crucial in preventing complications and increasing treatment success in CIP.
Zitieren
APA
Ataman, Ş., Kozak, H. H., Leba, L. K., & Ataman, S. (2026). Critical Illness Polyneuropathy Developing In The Early Period After An Epileptic Seizure: Two Case Reports. Journal of Emergency Medicine Case Reports, 17(1), 14-16. https://doi.org/10.33706/jemcr.1738131
Vancouver
Ataman Ş, Kozak HH, Leba LK, Ataman S. Critical Illness Polyneuropathy Developing In The Early Period After An Epileptic Seizure: Two Case Reports. Journal of Emergency Medicine Case Reports. 2026;17(1):14-16. doi:10.33706/jemcr.1738131
BibTeX
@article{Ataman2026,
author = {Ataman, Şeyma and Kozak, Hasan Hüseyin and Leba, Leyla Köse and Ataman, Sami},
title = {Critical Illness Polyneuropathy Developing In The Early Period After An Epileptic Seizure: Two Case Reports},
journal = {Journal of Emergency Medicine Case Reports},
year = {2026},
volume = {17},
number = {1},
pages = {14--16},
doi = {10.33706/jemcr.1738131}
}
EUVIMED